Cipla150mg 682 Pill — WHITE CAPSULE, 17mm — Pregabalin

No photo available

Imprint	Cipla150mg / 682
Colour	WHITE
Shape	CAPSULE
Size	17
Strength	PREGABALIN 150 mg
Dosage form	Capsule
Manufacturer	Cipla USA Inc.
NDC	69097-682
Schedule	CV
Availability	Prescription only
Ingredients	PREGABALIN[PREGABALIN]

What does this imprint mean?

The imprint "Cipla150mg 682" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Pregabalin

Uses and warnings

No boxed warning. Pregabalin is contraindicated in patients with "known hypersensitivity to pregabalin or any of its components," which has caused "angioedema" involving the throat, head, and neck that "may be associated with life-threatening respiratory compromise." The label also warns of the class-wide risk that "antiepileptic drugs, including LYRICA, increase the risk of suicidal thoughts or behavior"; dizziness and somnolence that can impair the ability to drive or operate machinery; and that pregabalin is a Schedule V controlled substance with potential for misuse and dependence. Abrupt or rapid discontinuation can precipitate withdrawal symptoms, including seizures in epilepsy patients.

Pregabalin capsules are indicated for the management of: - "Neuropathic pain associated with diabetic peripheral neuropathy (DPN)" - "Postherpetic neuralgia (PHN)" - "Fibromyalgia" - As "adjunctive therapy for adult patients with partial onset seizures"

Read the full drug profile →

How to identify this pill

• Check the imprint matches exactly: "Cipla150mg 682".
• Confirm the colour (WHITE) and shape (CAPSULE).
• Compare the size (17) against a ruler if possible.
• When in doubt, confirm with a pharmacist before taking any medication.

Similar-looking pills

WPI 3173

WHITE CAPSULE · Alendronate